33 Poster Discussion - XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile.
Saved in:
| Title: | 33 Poster Discussion - XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile. |
|---|---|
| Authors: | Hsu, J.1 (AUTHOR), Chong, C.1 (AUTHOR), Goon, L.1 (AUTHOR), Balayan, J.1 (AUTHOR), Wu, S.1 (AUTHOR), Johnson, E.1 (AUTHOR), Lorenzana, G.1 (AUTHOR), Bannen, L.2 (AUTHOR), Nguyen, L.3 (AUTHOR), Scheffold, C.4 (AUTHOR), Lamb, P.1 (AUTHOR), Xu, W.2 (AUTHOR), Yu, P.1 (AUTHOR) |
| Source: | European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS16-S16. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
